A petition calling for the UK to rejoin the European Union as a full member “as soon as possible” hit 100,000 signatures ...

The UK could be “less interesting” to pharma and life sciences firms after Brexit, the CEO of Roche has said, citing uncertainty over drug regulations and an unwillingness to use expensive ...

GlaxoSmithKline would consider buying Pfizer’s consumer health business – but only if the price is right, according to the company's chief executive. Emma Walmsley has also been busy shaking ...